Thermo Fisher Scientific Ushers in New Era of Clinical Mass Spectrometry with World's First Fully Integrated Laboratory Analyzer

Thermo Scientific Cascadion SM Clinical Analyzer Introduced at EuroMedLab 2017

Thermo Fisher Scientific has introduced the Thermo Scientific Cascadion SM Clinical Analyzer at EuroMedLab, bringing together the ease of use of clinical analyzers with the selectivity and sensitivity of liquid chromatography-tandem mass spectrometry (LC-MS/MS).

The fully automated analyzer is designed for use in a variety of settings, including hospital laboratories, and to provide results for a range of clinical tests. The Cascadion clinical analyzer will be available for demonstrations during EuroMedLab 2017, taking place June 11-15, in Athens, Greece. The Cascadion will be commercially available in Europe, followed by the U.S., once regulatory approvals have been received.

"Thermo Fisher is uniquely positioned to deliver an automated clinical analyzer that builds on our leading mass spectrometry platform," said Alan Sachs, chief scientific officer at Thermo Fisher Scientific. "It's designed to provide clinical laboratories with a solution that is both efficient and effective in providing results for some of the most sought after clinical tests. Cascadion has the potential to set new standards in the detection and measurement of specialty small molecule assays in the clinical lab."

The Cascadion system was completely designed and built using Thermo Fisher products and technologies. Featuring turnkey operation, it is designed to be used by laboratory staff with no specialized knowledge required.

For more information about the Cascadion SM Clinical Analyzer or other Thermo Fisher solutions for the clinical diagnostic laboratory, visit www.thermofisher.com/Cascadion.